The European League Against Rheumatism is one of the most relevant congresses in the world of rheumatology.
As a leading company in this field, IBSA will participate with a Satellite Symposium entirely focusing on our highly purified, pharmaceutical-grade chondroitin sulfate; in particular, very interesting data of the new clinical study (CONCEPT study) comparing chondroitin sulfate vs celebrex and vs placebo will be presented. See the full programme here.
All people interested in knowing more about IBSA as leading Company in the field of OA and Pain, and about its pipeline of products (Condrosulf/chondroitin sulphate; Sinovial/i.a. HA; Flector/diclofenac epolamine; Akis-Dicloin/subcutaneous diclofenac) are also invited to visit us in the exhibition hall (stand #900, Hall S12).
Watch videos of IBSA Satellite Symposium here